Startups are betting that partial reprogramming with Yamanaka factors may lead to age reversal, but hurdles remain.
Lex Fridman Podcast full episode: https://www.youtube.com/watch?v=jhKZIq3SlYE
Please support this podcast by checking out our sponsors:
- Onnit: https://lexfridman.com/onnit to get up to 10% off.
- Clear: https://clearme.com/lexpod and use code LexPod to get 2 months free.
- National Instruments (NI): https://www.ni.com/perspectives.
- SimpliSafe: https://simplisafe.com/lex and use code LEX to get a free security camera.
- Linode: https://linode.com/lex to get $100 free credit.
GUEST BIO:
David Sinclair is a geneticist at Harvard and author of Lifespan.
Continue reading “Meat-based vs Plant-based Diet for Longevity | David Sinclair and Lex Fridman” »
“Altos Labs is just the latest in a series of anti-aging research institutes to emerge recently. With so much money being poured into the science of living longer, there is reason to be optimistic for those hoping to reach longevity escape velocity.”
https://www.futuretimeline.net/images/backgrounds/join-our-f…ground.jpg #longevity
Altos Labs, a new biotech startup focused on deep biology of cellular rejuvenation programming, has been launched with $3bn in funding.
For it is they who are leading a charge towards a new frontier in medicine that will revolutionise our ‘healthspans’ — the number of years of good health we can expect to enjoy — and push back the worst effects of ageing.
The announcement this week that a new anti-ageing company, Altos Labs, which is based in the U.S. and UK, has been established to ‘hack’ the ageing process has reignited interest in the science of rejuvenation, an obsession that has spanned continents and the ages.
Jeff Bezos has backed anti-aging startup Alto Labs, which has recently hired former chief scientific officer of GlaxoSmithKline Hal Barron as its CEO.
https://www.google.com/amp/s/amp.ft.com/content/2b869472-…28788e8dd4
“GlaxoSmithKline’s chief scientific officer Hal Barron will step down in August as he moves to lead a Silicon Valley anti-ageing start-up, dealing a blow to the pharma group as it races to rebuild its pipeline of drugs.”
Link: Big Pharma loses top scientist to anti-aging research.
GlaxoSmithKline’s chief scientific officer Hal Barron will step down in August as he moves to lead a Silicon Valley anti-ageing start-up, dealing a blow to the pharma group as it races to rebuild its pipeline of drugs.
Hal Barron, a veteran drug developer, helped shape GSK efforts when some shareholders raised concerns that chief executive Emma Walmsley’s lack of a scientific background was a hindrance. He will be replaced by internal candidate Tony Wood.
Continue reading “GSK loses top scientist to anti-ageing start-up” »
Google has been developing what is perhaps the company’s most ambitious project to date: a science startup that will pursue ‘solutions for aging’ with the intended goal of “solving death”.
Calico, a company directed by futurists to explore the concept of “singularity”, has partnered with pharmaceutical giants to research and trial new market drugs that target aging and development.
What is this new audacious project? Who is behind it? In the following feature, Ethan Nash explores.
Rejuvenation has been a fantasy since the dawn of storytelling. Could an instant unicorn make it come true? | Science & technology.
The back of your eye, called the retina, reveals a wealth of health information to doctors, and may one day show your body’s true biological age, regardless of how old you are.
